Boston Scientific Corporation $BSX Holdings Increased by PBU The Pension Fund of Early Childhood & Youth Educators

PBU The Pension Fund of Early Childhood & Youth Educators lifted its stake in Boston Scientific Corporation (NYSE:BSX) by 18.8% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 263,677 shares of the medical equipment provider’s stock after purchasing an additional 41,713 shares during the period. PBU The Pension Fund of Early Childhood & Youth Educators’ holdings in Boston Scientific were worth $11,510,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Werba Rubin Papier Wealth Management purchased a new position in Boston Scientific in the third quarter worth approximately $239,000. R Squared Ltd purchased a new stake in shares of Boston Scientific in the 3rd quarter valued at approximately $365,000. Nan Fung Trinity HK Ltd. purchased a new stake in shares of Boston Scientific in the 3rd quarter valued at approximately $31,777,000. Van Strum & Towne Inc. purchased a new stake in shares of Boston Scientific in the 3rd quarter valued at approximately $1,777,000. Finally, Alpha Wealth Funds LLC raised its holdings in shares of Boston Scientific by 1,833.3% in the 3rd quarter. Alpha Wealth Funds LLC now owns 23,200 shares of the medical equipment provider’s stock valued at $1,018,000 after purchasing an additional 22,000 shares in the last quarter. 89.07% of the stock is owned by institutional investors and hedge funds.

Boston Scientific Trading Down 2.0%

NYSE BSX opened at $44.22 on Friday. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.36 and a quick ratio of 0.81. The firm’s fifty day moving average price is $44.05 and its 200 day moving average price is $54.75. The company has a market capitalization of $64.10 billion, a price-to-earnings ratio of 18.74, a price-to-earnings-growth ratio of 1.34 and a beta of 0.60. Boston Scientific Corporation has a 12 month low of $39.57 and a 12 month high of $105.65.

Boston Scientific (NYSE:BSX) last announced its quarterly earnings results on Wednesday, October 28th. The medical equipment provider reported $0.73 EPS for the quarter, hitting the consensus estimate of $0.73. Boston Scientific had a net margin of 16.62% and a return on equity of 18.61%. The firm had revenue of $5.14 billion for the quarter, compared to analyst estimates of $5.09 billion. During the same period last year, the business earned $0.75 EPS. Boston Scientific’s revenue for the quarter was up 1.4% compared to the same quarter last year. On average, sell-side analysts expect that Boston Scientific Corporation will post 3.17 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on the stock. Oppenheimer cut shares of Boston Scientific from an “outperform” rating to a “market perform” rating in a research report on Thursday, October 29th. TD Cowen lowered Boston Scientific from a “buy” rating to a “hold” rating and dropped their target price for the company from $56.00 to $46.00 in a report on Friday, October 30th. Wall Street Zen cut Boston Scientific from a “buy” rating to a “hold” rating in a research note on Sunday, August 2nd. Barclays decreased their price target on Boston Scientific from $48.00 to $45.00 and set an “equal weight” rating for the company in a report on Friday, October 30th. Finally, Leerink Partners lowered their price objective on Boston Scientific from $55.00 to $50.00 and set an “outperform” rating for the company in a research report on Thursday, October 29th. One research analyst has rated the stock with a Strong Buy rating, twenty have issued a Buy rating, eight have given a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $61.43.

About Boston Scientific

Boston Scientific is a medical technology company that develops, manufactures and markets devices used in minimally invasive procedures across a range of medical specialties. Founded in 1979, the company is headquartered in Marlborough, Massachusetts. Its products support areas including cardiovascular care, endoscopy, urology and neuromodulation. They include catheter-based devices and therapies for conditions affecting the heart and blood vessels, as well as devices used in diagnostic and therapeutic procedures involving the digestive and urinary systems.